Sechenov School
Home › Pharmacology › Rifampicin

Rifampicin

*Rifampicinum*

For medical students2 min readUpdated 2026-10-10

Rifampicin is a potent antibacterial drug that selectively blocks RNA synthesis in bacterial cells. It is a cornerstone of therapy for pulmonary and extrapulmonary forms of tuberculosis, as well as leprosy, and must always be administered as part of a multi-drug regimen.

Primary targetsPathogens of tuberculosis (*Mycobacterium tuberculosis*) and leprosy (*Mycobacterium leprae*).
MechanismSelective blockade of bacterial DNA-dependent RNA polymerase.
AdministrationOral (*per os*) or intravenous, strictly in combination therapy.
Key featureTurns body fluids (urine, saliva, tears) orange-red.

Pharmacodynamics: Mechanism of Action and Spectrum of Activity

Rifampicin is an antibacterial agent with a well-defined mechanism of action. The primary target of this drug is the bacterial enzymatic system, specifically causing potent inhibition of bacterial DNA-dependent RNA polymerase. This process results in the complete blockade of bacterial RNA synthesis, preventing further functioning and replication of the bacteria.

A crucial aspect of pharmacodynamics is its high selectivity. Students often question the safety of this mechanism for the human host. The answer lies in enzyme structure: the drug specifically binds only to bacterial polymerase and does not affect human RNA polymerase, ensuring safety for the patient.

The spectrum of activity comprises two main directions:

Clinical Use and Principles of Therapy

In clinical practice, the drug is used to treat both pulmonary and extrapulmonary forms of tuberculosis. Depending on the patient's condition, two main administration routes are available: oral (per os) or intravenous.

The core principle of therapy that every future physician must understand is that the drug is prescribed exclusively as part of combination therapy. Using it as monotherapy is a major clinical error. Mycobacteria have a high mutation rate, and a combined approach is critical to prevent the development of drug resistance. In practice, it is most commonly combined with other potent agents such as isoniazid.

Side Effects and Toxicity

Like any potent pharmacological agent, this antibiotic has several side effects that require careful monitoring by the physician.

Main categories of adverse reactions:

  1. Hepatotoxicity: the drug can cause significant liver function impairment, requiring regular monitoring of hepatic panels.
  2. Hematologic abnormalities: blood disorders such as thrombocytopenia (decreased platelet count) and anemia may occur.
  3. Gastrointestinal tract: patients frequently report dyspeptic symptoms associated with drug intake.

Of particular note is the so-called "flu-like syndrome." It presents with a classic triad of symptoms mimicking a viral infection: fever, arthralgia (severe joint pain), and myalgia (muscle pain).

Specific Effect: Patient Counseling

One of the most striking and memorable effects of the drug poses no threat to health, but holds immense significance for the patient's psychological comfort: the specific discoloration of body fluids.

During treatment, urine, saliva, and even tears acquire a rich orange-red color. Medically, this phenomenon is completely harmless. However, for an uninformed patient, the sudden appearance of orange tears or urine can cause severe stress and anxiety. Therefore, a vital duty of the physician is to inform the patient in advance about this specific effect before starting treatment.

Mnemonic

To easily remember the essence of the drug, use the "R" rule: Rifampicin blocks RNA synthesis by binding to RNA polymerase, and turns body fluids Red (orange).

Frequently asked questions

What drugs, aside from isoniazid, is rifampicin combined with in tuberculosis treatment?

In tuberculosis treatment, rifampicin is combined with other first-line core drugs and fluoroquinolones.

In addition to isoniazid, treatment regimens include:

  • Pyrazinamide — possesses bactericidal activity and retains activity in the acidic environment of caseum.
  • Ethambutol — suppresses mycobacterial replication, though it penetrates poorly into the central nervous system.
  • Levofloxacin — used in standard regimens to completely suppress the microbial population.
  • Streptomycin — a first-line agent administered in combination therapy to prevent resistance development.
How does rifampicin affect the hepatic cytochrome P450 system?

Rifampicin is a potent inducer of hepatic microsomal enzymes, particularly the cytochrome P450 system.

It increases the activity of these enzymes, leading to accelerated metabolism and inactivation of other drugs. The clinical consequence is a shortened duration of action and a reduced therapeutic effect of co-administered dependent drugs. These agents include:

  • Oral anticoagulants — e.g., warfarin.
  • Glucocorticoids.
  • Oral contraceptives.
  • Oral hypoglycemic agents.
  • Other drugs — digoxin, theophylline, quinidine.
Why is rifampicin safe for human cells if it blocks RNA synthesis?

The drug exhibits high selectivity. It inhibits exclusively bacterial DNA-dependent RNA polymerase and has no effect on the corresponding enzyme in human host cells.

Can rifampicin be prescribed as monotherapy?

Categorically no. To prevent the rapid development of mycobacterial resistance, it is used only as part of combination therapy, very frequently alongside isoniazid.

A patient complains of joint and muscle pain while taking the drug. What is this?

This is a manifestation of the "flu-like syndrome," which includes fever, myalgia (muscle pain), and arthralgia (joint pain). This is a known adverse effect of this antibiotic.

Should the drug be discontinued if the patient's urine turns orange?

No, this is a specific yet completely harmless effect. Body fluids take on an orange hue, which the patient must be warned about in advance to prevent unwarranted anxiety.

Go deeper

More topics in Pharmacology

AntiandrogensAntisyphilitic DrugsHypothalamic Hormones and Their AnalogsThyroid Medications: Replacement and Antithyroid DrugsIsoniazidHypoglycemic AgentsChlorpromazineErgometrine MaleateEthambutolSecond-Line Antitubercular DrugsBetaine PepsinRational Antibiotic CombinationPharmacology →